Protagonist Therapeutics: Buy rating nach Absturz

https://www.analystratings.com/articles/...agonist-therapeutics-ptgx/

Hintergrund des Absturzes:

https://investorplace.com/2021/09/...nvestorPlace+%28InvestorPlace%29



https://www.protagonist-inc.com/pipeline/  

https://www.nasdaq.com/market-activity/stocks/ptgx/real-time  

Daher fällt es wohl weiter stark:

Investors should probably assume the entire rusfertide program is toast. Convincing the FDA an early clinical-stage drug doesn't cause cancer is nearly impossible when the agency doesn't allow a company to run any trials.

https://www.fool.com/investing/2021/09/17/...s-stock-is-tanking-toda/  

https://www.fool.com/investing/2021/09/20/.../?source=iedfolrf0000001  

https://www.nasdaq.com/de/market-activity/stocks/ptgx/real-time  

https://www.finanzen.net/nachricht/aktien/...s-strength-last-10556185